0001562180-18-003488.txt : 20180803 0001562180-18-003488.hdr.sgml : 20180803 20180803193543 ACCESSION NUMBER: 0001562180-18-003488 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180802 FILED AS OF DATE: 20180803 DATE AS OF CHANGE: 20180803 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Calcaterra Chris M. CENTRAL INDEX KEY: 0001640771 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37463 FILM NUMBER: 18993237 MAIL ADDRESS: STREET 1: C/O GLAUKOS CORPORATION STREET 2: 26051 MERIT CIRCLE, SUITE 103 CITY: LAGUNA HILLS STATE: CA ZIP: 92653 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GLAUKOS Corp CENTRAL INDEX KEY: 0001192448 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 229 AVENIDA FABRICANTE CITY: SAN CLEMENTE STATE: CA ZIP: 92672 BUSINESS PHONE: 949-367-9600 MAIL ADDRESS: STREET 1: 229 AVENIDA FABRICANTE CITY: SAN CLEMENTE STATE: CA ZIP: 92672 FORMER COMPANY: FORMER CONFORMED NAME: GLAUKOS CORP DATE OF NAME CHANGE: 20020925 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2018-08-02 false 0001192448 GLAUKOS Corp GKOS 0001640771 Calcaterra Chris M. C/O GLAUKOS CORPORATION 229 AVENIDA FABRICANTE SAN CLEMENTE CA 92672 false true false false Chief Operating Officer Common Stock 2018-08-02 4 M false 38983.00 16.49 A 278983.00 D Common Stock 2018-08-02 4 S false 34361.00 44.31 D 244622.00 D Common Stock 2018-08-02 4 S false 4522.00 45.40 D 240100.00 D Common Stock 2018-08-02 4 S false 100.00 46.29 D 240000.00 D Stock Options (Right to buy) 16.49 2018-08-02 4 M false 38983.00 0.00 D 2026-03-10 Common Stock 38983.00 60417.00 D These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. This transaction was executed in multiple trades at prices ranging from $44.00 to $44.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $45.00 to $45.925. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This option was granted on March 10, 2016, and has a four-year vesting schedule in which 25% vests on the first year anniversary date of the grant and the remainder vests in equal monthly installments for 36 months thereafter, such that the stock option vests in full on the four-year anniversary of the grant date. /s/ Robert Davis, Attorney-in-Fact 2018-08-02